Mesoblast Limited (NASDAQ:MESO) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript February 28, 2025 Silviu Itescu: Good morning, everybody. I’m Silviu Itescu. I’m the Chief ...
Times News2d
FDA approves painkiller designed to eliminate risk of addiction
WASHINGTON — Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like ... drug pipeline that involves ...
HUB2d
Unknown substance
Anywhere from 2 million to 15 million people use kratom each year. While the substance does induce feelings of mild euphoria, ...
clinicalpainadvisor.com2d
Updated Sublocade Label Includes Rapid Induction, Alternative Injection Sites
The FDA has approved updated labeling for Sublocade (buprenorphine extended-release) injection to include a rapid induction protocol and alternative injection sites.
dailyguidenetwork3d
FDA Probes Unapproved Drugs Import Report
THE FOOD and Drugs Authority (FDA) has announced the initiation of an investigation into a recent report by BBC Africa Eye, ...
What is a public health crisis, and why do we have so many of them?
Northwell Health partnered with Stacker to analyze federal resources and news articles to illustrate how health crisis ...
KTLA-TV Los Angeles on MSN3d
FDA approves new opioid-free painkiller
Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the ...
pharmaphorum4d
Indivior changes CEO after warning sales will fall in 2025
The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...
manilatimes4d
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
Spark Biomedical, Inc. is a leading U.S.-based medical device developer, committed to unlocking the potential of bioelectronic medicine and bringing to market novel wearable neurostimulation treatment ...
R Street Institute4d
Stacey McKenna Statement for the Record, Hearing on “Combating the Opioid Epidemic”
The Honorable Rick ScottChairSpecial Committee on AgingUnited States SenateWashington, D.C. 20510 The Honorable Kirsten GillibrandRanking MemberSpecial Committee on AgingUnited States SenateWashington ...
Ensuring Alabama drug coverage policies are not pushing patients toward addictive substances: op-ed
SB161 would require that non-opioid pain treatments that have FDA approval be included on this preferred drug list with coverage terms that are no more restrictive than those given to opioid pain ...